Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humanized mice for modeling human infectious disease: challenges, progress, and outlook.
Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, Kremsdorf D, Manns MP, Manz MG, Mention JJ, Ott M, Rathinam C, Rice CM, Rongvaux A, Stevens S, Spits H, Strick-Marchand H, Takizawa H, van Lent AU, Wang C, Weijer K, Willinger T, Ziegler P. Legrand N, et al. Among authors: van lent au. Cell Host Microbe. 2009 Jul 23;6(1):5-9. doi: 10.1016/j.chom.2009.06.006. Cell Host Microbe. 2009. PMID: 19616761 Free PMC article. Review.
Human thymus regeneration and T cell reconstitution.
Legrand N, Dontje W, van Lent AU, Spits H, Blom B. Legrand N, et al. Among authors: van lent au. Semin Immunol. 2007 Oct;19(5):280-8. doi: 10.1016/j.smim.2007.10.001. Epub 2007 Nov 9. Semin Immunol. 2007. PMID: 17997107 Review.
Immunopathogenesis of IBD: insufficient suppressor function in the gut?
Huibregtse IL, van Lent AU, van Deventer SJ. Huibregtse IL, et al. Among authors: van lent au, van deventer sj. Gut. 2007 Apr;56(4):584-92. doi: 10.1136/gut.2006.103523. Epub 2006 Oct 17. Gut. 2007. PMID: 17047100 Free PMC article. Review. No abstract available.
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, Maas M, Mertz M, Veninga V, Bounova G, Broeks A, Beets-Tan RG, de Wijkerslooth TR, van Lent AU, Marsman HA, Nuijten E, Kok NF, Kuiper M, Verbeek WH, Kok M, Van Leerdam ME, Schumacher TN, Voest EE, Haanen JB. Chalabi M, et al. Among authors: van lent au. Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6. Nat Med. 2020. PMID: 32251400 Clinical Trial.
25 results